Adarza BioSystems

About:

Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.

Twitter/X: adarzabio

Top Investors: Arch Grants, BioGenerator, Cultivation Capital, Missouri Technology Corporation, CSC Upshot

Description:

Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip. It was founded in 2008 and headquartered in St Louis, Missouri.

Total Funding Amount:

$64.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)adarzabio.com

Founders:

Benjamin L. Miller, Christopher Striemer, Rand Henke

Number of Employees:

11-50

Last Funding Date:

2020-02-04

IPO Status:

Private

Industries: